News

Pfizer's oral COVID-19 antiviral, Paxlovid, would still be effective against the emerging Omicron variant, CEO Albert Bourla said. (Pfizer) The efficacy data for Pfizer’s oral COVID-19 drug now look so…

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and accessory proteins responsible for virus replication once inside a host…

A new study published in the journal Science Immunology analyzed lung epithelial cells from patients infected with COVID-19 and found the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces the complement system…